{"id":980804,"date":"2026-07-10T16:33:51","date_gmt":"2026-07-10T20:33:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/"},"modified":"2026-07-10T16:33:51","modified_gmt":"2026-07-10T20:33:51","slug":"vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/","title":{"rendered":"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">WASHINGTON<\/span>, <span class=\"legendSpanClass\">July 10, 2026<\/span> \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in a fireside chat at the B. Riley Securities Mind, Muscle &amp; Vision Summit in Boston, Massachusetts on Thursday, July 16, 2026.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <img decoding=\"async\" src=\"https:\/\/mmx.prnewswire.com\/media\/MS637926\/VandaLogo-v1.jpg?id=OA2759097\" title=\"Vanda Logo\" alt=\"Vanda Logo\" \/>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>About Vanda Pharmaceuticals Inc.<\/b>\n      <\/p>\n<p>Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4729545-1&amp;h=2105790135&amp;u=http%3A%2F%2Fwww.vandapharma.com%2F&amp;a=www.vandapharma.com\" target=\"_blank\" rel=\"nofollow\">www.vandapharma.com<\/a> and follow us on X @vandapharma.<\/p>\n<p>\n        <b><br \/>\n          <u>Corporate Contact:<br \/><\/u><br \/>\n        <\/b>Kevin Moran<br \/>Senior Vice President, Chief Financial Officer and Treasurer<br \/>Vanda Pharmaceuticals Inc.<br \/>202-734-3400<br \/><a href=\"mailto:pr@vandapharma.com\" target=\"_blank\" rel=\"nofollow\">pr@vandapharma.com<\/a><\/p>\n<p>Jim Golden \/ Jack Kelleher \/ Dan Moore<br \/>Collected Strategies<br \/><a href=\"mailto:VANDA-CS@collectedstrategies.com\" target=\"_blank\" rel=\"nofollow\">VANDA-CS@collectedstrategies.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=PH02357&amp;sd=2026-07-10\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle--vision-summit-302823067.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle&#8211;vision-summit-302823067.html<\/a><\/p>\n<p>SOURCE Vanda Pharmaceuticals Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH02357&amp;Transmission_Id=202607101630PR_NEWS_USPR_____PH02357&amp;DateId=20260710\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire WASHINGTON, July 10, 2026 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in a fireside chat at the B. Riley Securities Mind, Muscle &amp; Vision Summit in Boston, Massachusetts on Thursday, July 16, 2026. About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma. Corporate Contact: Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com Jim Golden \/ Jack Kelleher \/ Dan MooreCollected StrategiesVANDA-CS@collectedstrategies.com View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle&#8211;vision-summit-302823067.html SOURCE Vanda &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-980804","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire WASHINGTON, July 10, 2026 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in a fireside chat at the B. Riley Securities Mind, Muscle &amp; Vision Summit in Boston, Massachusetts on Thursday, July 16, 2026. About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma. Corporate Contact: Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com Jim Golden \/ Jack Kelleher \/ Dan MooreCollected StrategiesVANDA-CS@collectedstrategies.com View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle&#8211;vision-summit-302823067.html SOURCE Vanda &hellip; Continue reading &quot;Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-10T20:33:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS637926\/VandaLogo-v1.jpg?id=OA2759097\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit\",\"datePublished\":\"2026-07-10T20:33:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/\"},\"wordCount\":148,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS637926\\\/VandaLogo-v1.jpg?id=OA2759097\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/\",\"name\":\"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS637926\\\/VandaLogo-v1.jpg?id=OA2759097\",\"datePublished\":\"2026-07-10T20:33:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS637926\\\/VandaLogo-v1.jpg?id=OA2759097\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS637926\\\/VandaLogo-v1.jpg?id=OA2759097\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/","og_locale":"en_US","og_type":"article","og_title":"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit - Market Newsdesk","og_description":"PR Newswire WASHINGTON, July 10, 2026 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in a fireside chat at the B. Riley Securities Mind, Muscle &amp; Vision Summit in Boston, Massachusetts on Thursday, July 16, 2026. About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma. Corporate Contact: Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com Jim Golden \/ Jack Kelleher \/ Dan MooreCollected StrategiesVANDA-CS@collectedstrategies.com View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle&#8211;vision-summit-302823067.html SOURCE Vanda &hellip; Continue reading \"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-10T20:33:51+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS637926\/VandaLogo-v1.jpg?id=OA2759097","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit","datePublished":"2026-07-10T20:33:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/"},"wordCount":148,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS637926\/VandaLogo-v1.jpg?id=OA2759097","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/","name":"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS637926\/VandaLogo-v1.jpg?id=OA2759097","datePublished":"2026-07-10T20:33:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS637926\/VandaLogo-v1.jpg?id=OA2759097","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS637926\/VandaLogo-v1.jpg?id=OA2759097"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle-vision-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=980804"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980804\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=980804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=980804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=980804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}